Effects of the nicotinic acid analogue niceritrol on lipoprotein Lp(a) and coagulation-fibrinolysis status in patients with chronic renal failure on hemodialysis

Nephron

Volumn 77, Issue 1, 1997, Pages 112-113

  Shoji, Tetsuo ^a   Nishizawa, Yoshiki ^a   Kawasaki, Koichi ^a   Tabata, Tsutomu ^b   Matsushita, Yoshiki ^b   Inoue, Takashi ^b   Moriia, Hirotoshi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Soryukai Inoue Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; LIPOPROTEIN A; NICERITROL;

ADULT; BLOOD CLOTTING; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; FEMALE; FIBRINOLYSIS; HEMODIALYSIS; HUMAN; LETTER; MALE; PRIORITY JOURNAL;

ANTILIPEMIC AGENTS; BLOOD COAGULATION; FEMALE; FIBRINOLYSIS; HUMANS; KIDNEY FAILURE, CHRONIC; LIPOPROTEIN(A); MALE; MIDDLE AGED; NICERITROL; RENAL DIALYSIS;

EID: 0030882057     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000190257     Document Type: Letter

References (9)

1. Lindner A, Charra B, Sherrard DJ, Scribner BH: Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974;290:697-701.
2. Parsy D, Dracon M, Cachera C, et al: Lipoprotein abnormalities in chronic hemodialysis patients. Nephrol Dial Transplant 1988:3:51-56.
3. Shoji T, Nishizawa Y, Nishitani H, Yamakawa M, Morii H: High serum lipoprotein (a) concentrations in uremic patients treated with continuous ambulatory peritoneal dialysis. Clin Nephrol 1992:38:271-276.
4. MBewu AD, Durrington PN: Lipoprotein (a): Structure, properties and possible involvement in ihrombogcnesis and atherogenesis. Alhero-sclerosis 1990:85:1-14.
5. McLean JW, Tomlinson JE, Kuang W-J, Eaton DL, Chen EY, Fless GM, Scanu AM, Lawn RM: cDNA sequence of human apolipoprotcin (a) is homologous to plasminogen. Nature 1987;300:132-137.
6. Hajjar KA, Gavish D, Breslow JL, Nachman RL: Lipoprotein (a) modulation of endothelial surface fibrinolysis and its potential role in atherosclerosis. Nature 1989:339:303-305.
7. Carlson LA, Hamsten A, Asplund A: Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid. J Intern Med 1989:226: 271-276.
8. Shoji T, Nishizawa Y, Nishitani H, Yamakawa M, Morii H: Impaired high density lipoprotein metabolism in uremic patients. Kidney Int 1992:41:1653-1661.
9. Sundell IB, Nilsson TK, Hallmans G, Hellsten G, Dahlen GH: Interrelationships between plasma levels of plasminogen activator inhibitor, tissue plasminogen activator, lipoprotein (a) and established cardiovascular risk factors in a North Swedish population. Atherosclerosis 1989:80:9-16.